CN101076320A - 吉哌隆的高剂量延时释放制剂 - Google Patents

吉哌隆的高剂量延时释放制剂 Download PDF

Info

Publication number
CN101076320A
CN101076320A CNA2004800445809A CN200480044580A CN101076320A CN 101076320 A CN101076320 A CN 101076320A CN A2004800445809 A CNA2004800445809 A CN A2004800445809A CN 200480044580 A CN200480044580 A CN 200480044580A CN 101076320 A CN101076320 A CN 101076320A
Authority
CN
China
Prior art keywords
compositions
tablet
gepirone
inch
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800445809A
Other languages
English (en)
Chinese (zh)
Inventor
S·J·克雷默
L·F·法布雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lay Mines Holdings Ltd
Original Assignee
Lay Mines Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lay Mines Holdings Ltd filed Critical Lay Mines Holdings Ltd
Publication of CN101076320A publication Critical patent/CN101076320A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2004800445809A 2004-11-05 2004-11-05 吉哌隆的高剂量延时释放制剂 Pending CN101076320A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/032785 WO2006052227A1 (en) 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone

Publications (1)

Publication Number Publication Date
CN101076320A true CN101076320A (zh) 2007-11-21

Family

ID=36336794

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800445809A Pending CN101076320A (zh) 2004-11-05 2004-11-05 吉哌隆的高剂量延时释放制剂

Country Status (11)

Country Link
EP (1) EP1809255A4 (ru)
JP (1) JP2008519071A (ru)
CN (1) CN101076320A (ru)
AU (1) AU2004324868B2 (ru)
BR (1) BRPI0419179A (ru)
CA (1) CA2585606A1 (ru)
EA (1) EA013213B1 (ru)
IL (1) IL182792A0 (ru)
MX (1) MX2007005368A (ru)
NO (1) NO20072851L (ru)
WO (1) WO2006052227A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131906A1 (it) 2013-11-18 2015-05-19 Gnosis Spa Composizioni solide orali a lento rilascio
RU2713725C1 (ru) * 2019-02-08 2020-02-06 Юрий Владимирович Соколов Биологически активная добавка и способ ее применения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
US6534507B1 (en) * 1999-12-20 2003-03-18 Fabre-Kramer Pharmaceuticals, Inc. Methods for treating psychological disorders using bioactive metabolites of gepirone
KR20040018314A (ko) * 2000-12-08 2004-03-03 악조 노벨 엔.브이. 게피론을 함유하는 경구 투여용 연장 방출형 제제
US20030220346A1 (en) * 2000-12-18 2003-11-27 Kramer Stephen J. Use of bioactive metabolites of gepirone for the treatment of psychological disorders

Also Published As

Publication number Publication date
NO20072851L (no) 2007-07-31
MX2007005368A (es) 2007-09-11
AU2004324868B2 (en) 2010-04-29
IL182792A0 (en) 2007-08-19
EA200701010A1 (ru) 2007-10-26
WO2006052227A1 (en) 2006-05-18
CA2585606A1 (en) 2006-05-18
BRPI0419179A (pt) 2007-12-18
JP2008519071A (ja) 2008-06-05
AU2004324868A1 (en) 2006-05-18
EA013213B1 (ru) 2010-04-30
EP1809255A1 (en) 2007-07-25
EP1809255A4 (en) 2011-08-03

Similar Documents

Publication Publication Date Title
CN1126536C (zh) 用于控制释放活性物质的药物组合物
CN1289082C (zh) 用于治疗糖尿病的药物组合物
CN1309380C (zh) 治疗代谢紊乱、特别是糖尿病或与糖尿病相关的疾病或疾患的药物
CN1111404C (zh) 控释的羟丁宁制剂
CN1282456C (zh) 帕罗西汀控释组合物
CN1227004C (zh) 治疗充血性心力衰竭的部分脂肪酸氧化抑制剂
CN1284867A (zh) 生产咀嚼分散片的方法
CN1305376A (zh) 治疗糖尿病的药物组合物
CN1874767A (zh) 包含aplindore和其衍生物的缓释药物组合物
CN100335060C (zh) 细胞色素p450依赖性蛋白酶抑制剂的组合物
CN1461212A (zh) 水凝胶驱动的药物剂型
CN1302605A (zh) 缓释的口服给药组合物
CN1301534A (zh) 稳定的缓释口服给药组合物
CN1929821A (zh) 包含匹莫苯的药物组合物
CN1671382A (zh) 普拉克索的缓释片组合物
CN1216467A (zh) 西沙必利的速释pH－非依赖性固体剂型
CN1031183A (zh) 二氢吡啶贮存制剂
CN1762357A (zh) 一种莫西沙星口服药物制剂及其制备方法
CN1723021A (zh) 稳定的口服固体药物组合物
CN1679955A (zh) 可提高用药安全的药物组合物
CN1446535A (zh) 盐酸[R－(Z)]－α－甲氧亚氨基－α－(1－氮杂双环[2.2.2]辛－3－基)乙腈控释剂型
CN1649569A (zh) 控释剂型
CN1891218A (zh) 盐酸雷诺嗪缓释制剂及其制备方法
CN1684681A (zh) 比西发定制剂
CN101076320A (zh) 吉哌隆的高剂量延时释放制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20071121